Module

Rethinking the Role of NNRTIs: Clinical Strategies for Optimizing Outcomes With Next-Generation Agents

Source: CCO Print Series

Rethinking the Role of NNRTIs: Clinical Strategies for Optimizing Outcomes With Next-Generation Agents

Faculty:

Joseph J. Eron, Jr., MD
W. David Hardy, MD
Charles B. Hicks, MD

CME CREDIT INFORMATION

Release Date: 12/17/07

Expiration Date: 12/16/08

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.0 Nursing CE credit

Pharmacists: 1.1 contact hours (0.11 CEUs)

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Summarize recent clinical data on the safety and efficacy of next-generation NNRTIs
Describe the impact of NNRTI resistance mutations on response to both currently FDA-approved and next-generation NNRTIs
Discuss the use of investigational or recently approved agents in combination with currently approved therapies to maximize outcomes in treatment-experienced HIV-infected patients

Topics covered include:

CME Test Instructions

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.